Timed out
A batsman is ruled timed out following the fall of a wicket if they do not occupy the crease within a set time. The new batsman is then out just as if they had been bowled, stumped, run out or caught. Timeless match
a match which is played until both teams have completed their allotted innings or overs, regardless of how many days are required. Many early first-class matches were played in a timeless format, but the need for advanced scheduling has meant that timeless matches are seldom played today. Timing
the art of striking the ball so that it hits the bats sweet spot. A "well-timed" shot imparts great speed to the ball but appears effortless. Toe-crusher
A yorker bowled with inswing, aimed at the batsmans toes. Ton
see century. Top edge
the ball hitting the top edge of the bat when a batsman plays a cross-bat shot

Top order
the batsmen batting in the top 4 in the batting order. These are generally the most skilled batsmen in the team, equipped with the technique and temperament to continue batting for long periods, often for hours or a whole day. Top spin
forward rotation on the ball, causing it to increase speed immediately after pitching. Toss
the traditional flipping of a coin to determine which captain will have the right to choose whether to bat or field. Tour
An organised itinerary of matches requiring travel away from the teams usual base. Used especially in international cricket for the representative team of one nation playing a series of matches in another nation.
A total of 31 patients were treated with Glybera, most for free in clinical trials before the drug was taken off the market. Incidence
The disorder affects about 1 out of 1,000,000 people; however, epidemiological data are limited and there are regional differences due to cofounder effect (e.g. in Canada) or intermarriage. See also
Primary hyperlipoproteinemia
Familial apoprotein CII deficiency
List of cutaneous conditions

References
Further reading
Gaudet, D; de Wal, J; Tremblay, K; Déry, S; van Deventer, S; Freidig, A; Brisson, D; Méthot, J (June 2010). "Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency". Atherosclerosis. Supplements. 11 (1): 55–60. doi:10.1016/j.atherosclerosissup.2010.03.004. PMID 20427244. "LPL gene". NIH Genetics Home Reference. February 2015. Hegele, RA;  et al. (August 2014). "The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management". The Lancet. Diabetes & Endocrinology. 2 (8): 655–66. doi:10.1016/S2213-8587(13)70191-8. PMC 4201123. PMID 24731657. == External links ==